Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898534 · ClinicalTrials.gov registry record · Phase 4
Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus
A Phase 4 study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 234
- Enrollment target
NCT00898534: Completed Phase 4 study, sponsored by Boston Children's Hospital.
NCT00898534 is a Phase 4 study that has completed, run by Boston Children's Hospital. The registered enrollment target is 234 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00898534, a Phase 4 study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 234 participants
- Enrollment target
Study Summary
Immediate feedback of hemoglobin A1c (A1c) results to adults with type 1 and 2 diabetes allows more appropriate care decisions at the clinic visit and may improve glycemic control. The investigators' objective is to determine whether immediate feedback of A1c results to children with type 1 diabetes will improve patient care and glycemic control.
Interventions
- DEVICE Bayer DCA2000+ Hemoglobin A1c analyzer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2003-11 |
| Est. Completion | 2006-01 |
| Phase | Phase 4 |
What the finished NCT00898534 record still lists
NCT00898534 is an interventional study that assigns participants to a tested intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 1 intervention - of which Bayer DCA2000+ Hemoglobin A1c analyzer is the first listed.
NCT00898534 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00898534 about?
NCT00898534 is a clinical study titled "Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus". Immediate feedback of hemoglobin A1c (A1c) results to adults with type 1 and 2 diabetes allows more appropriate care decisions at the clinic visit and may improve glycemic control. The investigators' objective is to determine whether immediate feedback of A1c results to children with type 1 diabetes...
What is the current status of trial NCT00898534?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 234 participants. The study started on 2003-11. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00898534?
The interventions under investigation include: Bayer DCA2000+ Hemoglobin A1c analyzer (DEVICE).
Who is sponsoring clinical trial NCT00898534?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00898534's enrollment target sits among peer trials
234 369th of 2000 higher than 1,632 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
- NCT05444465 · 234 participants · NA
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
- NCT05720338 · 234 participants · Phase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia